For the year ending 2025-12-31, EXOZ has $5,971,517 in assets. $2,574,268 in debts. $3,039,343 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 3,039,343 | |||
| Grants receivable | 517,359 | |||
| Prepaid expenses and other current assets | 382,886 | |||
| Total current assets | 3,939,588 | |||
| Total property and equipment | 1,781,063 | |||
| Less accumulated depreciation | 1,016,662 | |||
| Property and equipment, net | 764,401 | |||
| Operating lease right-of-use asset, net | 1,053,641 | |||
| Finance lease right-of-use asset, net | 108,682 | |||
| Tax receivable | 105,205 | |||
| Total assets | 5,971,517 | |||
| Accounts payable | 1,235,337 | |||
| Due to affiliates | 5,330 | |||
| Operating lease liabilities current | 281,979 | |||
| Finance lease liabilities current | 44,255 | |||
| Total current liabilities | 1,566,901 | |||
| Deferred grant reimbursement | 90,365 | |||
| Operating lease liabilities - long term | 852,575 | |||
| Finance lease liabilities - long term | 64,427 | |||
| Total liabilities | 2,574,268 | |||
| Common shares, 100,000,000 authorized shares at 0.000001 8,406,681 and 8,367,810 shares issued and outstanding as of december 31, 2025, and december 31, 2024, respectively | 8 | |||
| Additional paid-in-capital | 24,501,933 | |||
| Accumulated (deficit) | -21,104,692 | |||
| Total stockholders equity | 3,397,249 | |||
| Total liabilities and stockholders equity (deficit) | 5,971,517 | |||
EXOZYMES INC. (EXOZ)
EXOZYMES INC. (EXOZ)